---
title: AACR 2023 On-Demand Posters
description: HUB Organoids presents latest organoid data at the 2023 AACR Meeting
image: https://resources.huborganoids.nl/hubfs/tile-aacr-2023-posters.png
---

[![Logo HUB Organoids](https://resources.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "Logo HUB Organoids")](https://huborganoids.nl/)

![merk-m-logo-blue](https://resources.huborganoids.nl/hs-fs/hubfs/merk-m-logo-blue.png?width=728&height=225&name=merk-m-logo-blue.png)

![](https://resources.huborganoids.nl/hs-fs/hubfs/Logo/AACR-logo-1.png?width=100&name=AACR-logo-1.png)

# On-demand posters

Check out the latest data on patient-derived organoids that HUB presented at AACR 2023 

![](https://resources.huborganoids.nl/hubfs/assets2023/thumb-organoids-co-cultures.png)

### Organoid co-cultures with autologous T cells to assess toxicity and efficacy of bispecific antibodies

*presented by Sylvia Boj, Chief Scientific Officer, HUB Organoids*

[![](https://resources.huborganoids.nl/hs-fs/hubfs/Assets%202022/btn-download.png?width=150&name=btn-download.png)](https://resources.huborganoids.nl/aacr-poster-2023-organoid-co-cultures-with-autologous-t-cells)

![](https://resources.huborganoids.nl/hubfs/assets2023/poster-thumb-tumour-and-organoid-t-cel.png)

### Tumor organoid and T-cell co-culture assay to evaluate CAR T-cell cytotoxicity

*presented by Eider Valle Encinas, Scientific Business Development Manager, HUB Organoids*

[![](https://resources.huborganoids.nl/hs-fs/hubfs/Assets%202022/btn-download.png?width=150&name=btn-download.png)](https://resources.huborganoids.nl/aacr-poster-2023-tumour-organoid-t-cell-co-culture-assay-to-evaluate-car-t-cell-cytotoxicity)

![](https://resources.huborganoids.nl/hubfs/assets2023/poster-thumb-patient-in-the-lab-organoid.png)

### Patient in the lab: Down-scaling patient-derived organoid screening for diagnostic purposes

*presented by Sylvia Boj, Chief Scientific Officer, HUB Organoids*

[![](https://resources.huborganoids.nl/hs-fs/hubfs/Assets%202022/btn-download.png?width=150&name=btn-download.png)](https://resources.huborganoids.nl/aacr-poster-2023-patient-in-the-lab)

![](https://resources.huborganoids.nl/hubfs/assets2023/poster-thumb-optimization-of-screening-conditions.png)

### Optimization of screening conditions using patient-derived organoids for diagnostic purposes

*presented by Carla Verissimo, Head of Department Oncology, HUB Organoids*

[![](https://resources.huborganoids.nl/hs-fs/hubfs/Assets%202022/btn-download.png?width=150&name=btn-download.png)](https://resources.huborganoids.nl/aacr-poster-2023-optimization-of-screening-conditions)

![](https://resources.huborganoids.nl/hubfs/assets2023/poster-thumb-autologous-organoids-t-cells.png)

### Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy development

*presented by Claudia Beaurivage, Senior Scientist, HUB Organoids*

[![](https://resources.huborganoids.nl/hs-fs/hubfs/Assets%202022/btn-download.png?width=150&name=btn-download.png)](https://resources.huborganoids.nl/aacr-poster-2023-autologous-organoids-and-t-cell-co-cultures)

![](https://resources.huborganoids.nl/hubfs/assets2023/poster-thumb-developing-patient-derived-organoid-biobank.png)

### Developing a patient-derived organoid biobank, suitable for large-scale drug screenings

*presented by Daniele Mori, Scientist, HUB Organoids*

[![](https://resources.huborganoids.nl/hs-fs/hubfs/Assets%202022/btn-download.png?width=150&name=btn-download.png)](https://resources.huborganoids.nl/aacr-poster-2023-developing-a-patient-derived-organoid-biobank)

![Logo HUB Organoids](https://resources.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "Logo HUB Organoids")

[Privacy Policy](https://huborganoids.nl/privacy-policy)

HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany

***FOR RESEARCH USE ONLY.**  Unless otherwise stated in our catalog or other company documentation  
 accompanying the product(s), our products are intended for research use only and are not to be used   
 for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro   
 diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to   
humans or animals.*